EKSO logo

Ekso Bionics Holdings (EKSO) Company Overview

Profile

Full Name:

Ekso Bionics Holdings, Inc.

Sector:

Healthcare

Industry:

Medical Instruments & Supplies

Country:

United States

IPO:

January 17, 2014

Indexes:

Not included

Website:

http://www.eksobionics.com

Description:

Ekso Bionics Holdings develops advanced robotic exoskeletons to assist individuals with mobility challenges. Their technology aims to improve rehabilitation for patients with spinal cord injuries and other conditions, enhancing movement and independence. The company focuses on innovation in wearable robotics for medical and industrial applications.

Key Details

Price

$0.49

Market Cap

$10.76 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$18.28 M(+41.57% YoY)

Annual EPS

-$1.10(+5.17% YoY)

PE Ratio

-

Annual ROE

-79.89%

Annual Debt To Equity

0.48

Beta

0.98

Events Calendar

Earnings

Next earnings date:

Mar 3, 2025

Recent quarterly earnings:

Oct 28, 2024

Recent annual earnings:

Mar 4, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Mar 25, 2020

Analyst ratings

Recent major analysts updates

Jan 14, 25 HC Wainwright & Co.
Buy
Oct 29, 24 Lake Street
Buy
Oct 29, 24 HC Wainwright & Co.
Buy
Jul 30, 24 HC Wainwright & Co.
Buy
Jun 24, 24 Lake Street
Buy
Apr 30, 24 HC Wainwright & Co.
Buy
Mar 5, 24 HC Wainwright & Co.
Buy
Jan 22, 24 HC Wainwright & Co.
Buy
Apr 28, 23 HC Wainwright & Co.
Buy
Mar 30, 23 HC Wainwright & Co.
Buy

Screeners with EKSO included

Growing Shares Outstanding
Stocks cheaper than 1 dollar
US stocks
Biggest stock losers today
Stocks below SMA 200
Most recommended stocks
Earnings today
Stocks below analysts price target
Healthcare sector
All stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.49
EKSO price is $0.49

Price All-time High

$803.25
EKSO price is currently -99.94% below its historical high of $803.25

Price Analysts Target

$5.50
EKSO price is currently -91.11% lower than the consensus analysts' forecast

Price Today Change

-6.8%
EKSO price is down -6.8% today

Price YTD Change

-21.11%
EKSO price is down -21.11% since January 1st

Price 3-Year Change

-80.89%
EKSO price is down -80.89% over the past 3 years

Market cap

Market Cap

$10.76 M
EKSO market capitalization is $10.76 million

Market Cap 3-Year Change

-66.89%
EKSO market capitalization is down -66.89% over the past 3 years

Market Cap All-time High

$777.63 M
EKSO market capitalization is currently -98.62% below its historical high of $777.63 million

Market Cap Sector Rank

18.67%
EKSO market capitalization is higher than 18.67% of companies in Healthcare sector

Technical

Beta

0.98
EKSO beta is 0.98

200-day SMA

$0.94
EKSO price is currently -47.83% below its 200-day simple moving average

14-day RSI

41.50
EKSO 14-day relative strength index is 41.50

30-day Relative Volume

0.67
EKSO 30-day relative volume is 0.67

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$18.28 M
EKSO annual revenue is $18.28 million

Annual Revenue Analysts Estimate

$17.87 M
EKSO annual revenue is currently +2.29% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

+41.57%
EKSO annual revenue is up +41.57% year-on-year

Annual Revenue Sector Rank

35.2%
EKSO annual revenue is higher than 35.2% of companies in Healthcare sector

Profit

Annual Gross Profit

$9.08 M
EKSO annual gross profit is $9.08 million

Annual Gross Margin

49.67%
EKSO annual gross profit margin is 49.67%

Annual Operating Profit

-$15.11 M
EKSO annual operating income is -$15.11 million

Annual Operating Margin

-82.67%
EKSO annual operating profit margin is -82.67%

Annual Net Income

-$15.20 M
EKSO annual net profit is -$15.20 million

Annual Net Margin

-83.14%
EKSO annual net profit margin is -83.14%

EPS

Annual EPS

-$1.10
EKSO annual earnings per share is -$1.10

Annual EPS Analysts Estimate

-
EKSO annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+5.17%
EKSO annual earnings per share is up +5.17% year-on-year

Annual EPS Sector Rank

58.22%
EKSO annual earnings per share is higher than 58.22% of companies in Healthcare sector

ROA & ROE

Annual ROA

-43.53%
EKSO annual return on assets is -43.53%

Annual ROE

-79.89%
EKSO annual return on equity is -79.89%

EBIT & EBITDA

Annual EBIT

-$14.90 M
EKSO annual earnings before interest & taxes is -$14.90 million

Annual EBITDA

-$13.20 M
EKSO annual EBITDA is -$13.20 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
EKSO price to earnings ratio value is unknown

PE Ratio Sector Rank

-
EKSO price to earnings ratio is unknown

PB Ratio

PB Ratio

0.72
EKSO price to book ratio is 0.72

PB Ratio Sector Rank

35.53%
EKSO price to book ratio is higher than 35.53% of companies in Healthcare sector

PS Ratio

PS Ratio

0.61
EKSO price to sales ratio is 0.61

PS Ratio Sector Rank

17.45%
EKSO price to sales ratio is higher than 17.45% of companies in Healthcare sector

Enterprise value

Enterprise Value

$8.81 M
EKSO enterprise value is $8.81 million

Enterprise Value Sector Rank

22.81%
EKSO enterprise value is higher than 22.81% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.96
EKSO EV/EBITDA is -0.96

EV/EBITDA Sector Rank

46.13%
EKSO EV/EBITDA is higher than 46.13% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.49
EKSO annual current ratio is 2.49

Annual Quick Ratio

1.87
EKSO annual quick ratio is 1.87

Leverage

Annual Debt To Equity

0.48
EKSO annual debt to equity ratio is 0.48

Annual Interest Coverage Ratio

-49.32
EKSO annual interest coverage ratio is -49.32

Risk & Stability

Piotroski F-Score

4
EKSO piotroski f-score is 4

Altman Z-Score

-11.75
EKSO altman z-score is -11.75

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$28.92 M
EKSO annual total assets is $28.92 million

Annual Non Current Assets

$8.71 M
EKSO annual long term assets is $8.71 million

Annual Current Assets

$20.21 M
EKSO annual total current assets is $20.21 million

Annual Cash & Cash Equivalents

$8.64 M
EKSO annual cash & cash equivalents is $8.64 million

Equity

Annual Book Value

$12.61 M
EKSO annual book value is $12.61 million

Annual Working Capital

$12.09 M
EKSO annual working capital is $12.09 million

Liabilities

Annual Total Liabilities

$16.31 M
EKSO annual total liabilities is $16.31 million

Annual Total Long Term Liabilities

$8.20 M
EKSO annual total long term liabilities is $8.20 million

Annual Current Liabilities

$8.12 M
EKSO annual total current liabilities is $8.12 million

Annual Accounts Payable

$1.85 M
EKSO annual accounts payable is $1.85 million

Debt

Annual Total Debt

$7.17 M
EKSO annual total debt is $7.17 million

Annual Total Debt 1-Year Change

-4.49%
EKSO annual total debt is down -4.49% year-on-year

Annual Long Term Debt

$5.55 M
EKSO annual long term debt is $5.55 million

Annual Short Term Debt

$1.61 M
EKSO annual short term debt is $1.61 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$33.39 M
EKSO annual total expenses is $33.39 million

Annual Operating Expenses

$24.19 M
EKSO annual total operating expenses is $24.19 million

Annual Cost Of Goods Sold

$9.20 M
EKSO annual cost of goods sold is $9.20 million

Annual SGA

$19.17 M
EKSO annual SGA is $19.17 million

Annual D&A

$1.70 M
EKSO annual depreciation & amortization is $1.70 million

Annual Interest Expense

$302.00 K
EKSO annual interest expense is $302.00 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$12.05 M
EKSO annual cash flow from operations is -$12.05 million

Annual CFO 1-Year Change

+17.93%
EKSO annual cash flow from operations is up +17.93% year-on-year

Annual CFI

-$157.00 K
EKSO annual cash flow from investing activities is -$157.00 thousand

Annual CFI 1-Year Change

+96.97%
EKSO annual cash flow from investing activities is up +96.97% year-on-year

Annual CFF

$348.00 K
EKSO annual cash flow from financing activities is $348.00 thousand

Annual CFF 1-Year Change

+100%
EKSO annual cash flow from financing activities is up +100% year-on-year

Free CashFlow

Annual FCF

-$12.21 M
EKSO annual free cash flow is -$12.21 million

Annual FCF 1-Year Change

+17.95%
EKSO annual free cash flow is up +17.95% year-on-year

CAPEX

Annual CAPEX

$157.00 K
EKSO annual capital expenditures is $157.00 thousand

Annual CAPEX 1-Year Change

-19.07%
EKSO annual capital expenditures is down -19.07% year-on-year

Institutional Ownership

Similar stocks

CLRB logo
Cellectar Biosciences (CLRB)
NERV logo
Minerva Neurosciences (NERV)
NeurAxis (NRXS)
INBS logo
Intelligent Bio Solutions (INBS)
MYNZ logo
Mainz Biomed BV (MYNZ)
XTLB logo
XTL Biopharmaceuticals (XTLB)
BLRX logo
BioLineRx (BLRX)
ACXP logo
Acurx Pharmaceuticals (ACXP)
PHGE logo
BiomX (PHGE)

FAQ

  • What is the ticker symbol for Ekso Bionics Holdings?
  • Does Ekso Bionics Holdings pay dividends?
  • What sector is Ekso Bionics Holdings in?
  • What industry is Ekso Bionics Holdings in?
  • What country is Ekso Bionics Holdings based in?
  • When did Ekso Bionics Holdings go public?
  • Is Ekso Bionics Holdings in the S&P 500?
  • Is Ekso Bionics Holdings in the NASDAQ 100?
  • Is Ekso Bionics Holdings in the Dow Jones?
  • When was Ekso Bionics Holdings's last earnings report?
  • When does Ekso Bionics Holdings report earnings?
  • Should I buy Ekso Bionics Holdings stock now?

What is the ticker symbol for Ekso Bionics Holdings?

The ticker symbol for Ekso Bionics Holdings is NASDAQ:EKSO

Does Ekso Bionics Holdings pay dividends?

No, Ekso Bionics Holdings does not pay dividends

What sector is Ekso Bionics Holdings in?

Ekso Bionics Holdings is in the Healthcare sector

What industry is Ekso Bionics Holdings in?

Ekso Bionics Holdings is in the Medical Instruments & Supplies industry

What country is Ekso Bionics Holdings based in?

Ekso Bionics Holdings is headquartered in United States

When did Ekso Bionics Holdings go public?

Ekso Bionics Holdings's initial public offering (IPO) was on January 17, 2014

Is Ekso Bionics Holdings in the S&P 500?

No, Ekso Bionics Holdings is not included in the S&P 500 index

Is Ekso Bionics Holdings in the NASDAQ 100?

No, Ekso Bionics Holdings is not included in the NASDAQ 100 index

Is Ekso Bionics Holdings in the Dow Jones?

No, Ekso Bionics Holdings is not included in the Dow Jones index

When was Ekso Bionics Holdings's last earnings report?

Ekso Bionics Holdings's most recent earnings report was on Oct 28, 2024

When does Ekso Bionics Holdings report earnings?

The next expected earnings date for Ekso Bionics Holdings is Mar 3, 2025

Should I buy Ekso Bionics Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions